Friday, September 11, 2026
30 C
Bengaluru

The Killer Nexus – What Really Ails Indian Healthcare?

For Every Bottle Of Killer Cough Syrup Doctor Prescribed, He Got Rs 2.5 As Cut https://www.ndtv.com/india-news/coldrif-madhya-pradesh-cough-syrup-deaths-dr-praveen-soni-for-every-bottle-of-killer-cough-syrup-doctor-prescribed-he-got-rs-2-5-as-cut-9453358 via @ndtv The syrup, manufactured by Sresan Pharmaceuticals, became the tragic link to the deaths of 23 children in the state.[10][11] Part I: The Drug Connection Investigations reveal that Dr Praveen Soni, a paediatrician at Parasia’s government health centre, continued prescribing…

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

Topics

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...
spot_img

Related Articles

spot_imgspot_img